Pulmonary artery denervation in patients with pulmonary hypertension: present state and clinical experience
D. A. Feshchenko,
B. A. Rudenko,
A. S. Shanoyan,
O. M. Drapkina,
A. V. Kontsevaya,
N. E. Gavrilova,
F. B. Shukurov,
D. K. Vasiliev https://doi.org/10.15829/1560-4071-2019-12-162-168
Abstract
Despite treatment advances, the prognosis of patients with both primary and secondary pulmonary hypertension (PH) remains unfavorable. The increased activity of the sympathetic nervous system is one of the universal mechanisms involved in the PH pathogenesis. Pulmonary artery denervation is a novel minimally invasive pathogenetic method of PH treatment. The denervation procedure is mainly implemented by using radiofrequency ablation of the pulmonary trunk, where most sympathetic nerve fibers are located. In this article we present an overview and analysis of the present state, results of various experimental and clinical studies, as well as clinical experience. The results of studies demonstrated the safety of endovascular surgery and its beneficial effect on both hemodynamic and clinical parameters.
About the Authors
D. A. Feshchenko
National Medical Center for Preventive Medicine
Russian Federation
Moscow
Competing Interests: Конфликт интересов не заявляется
Russian Federation
Moscow
Competing Interests: Конфликт интересов не заявляется
B. A. Rudenko
National Medical Center for Preventive Medicine
Russian Federation
Moscow
Competing Interests: Конфликт интересов не заявляется
Russian Federation
Moscow
Competing Interests: Конфликт интересов не заявляется
A. S. Shanoyan
National Medical Center for Preventive Medicine
Russian Federation
Moscow
Competing Interests: Конфликт интересов не заявляется
Russian Federation
Moscow
Competing Interests: Конфликт интересов не заявляется
O. M. Drapkina
National Medical Center for Preventive Medicine
Russian Federation
Moscow
Competing Interests: Конфликт интересов не заявляется
Russian Federation
Moscow
Competing Interests: Конфликт интересов не заявляется
A. V. Kontsevaya
National Medical Center for Preventive Medicine
Russian Federation
Moscow
Competing Interests: Конфликт интересов не заявляется
Russian Federation
Moscow
Competing Interests: Конфликт интересов не заявляется
N. E. Gavrilova
National Medical Center for Preventive Medicine
Russian Federation
Moscow
Competing Interests: Конфликт интересов не заявляется
Russian Federation
Moscow
Competing Interests: Конфликт интересов не заявляется
F. B. Shukurov
National Medical Center for Preventive Medicine
Russian Federation
Moscow
Competing Interests: Конфликт интересов не заявляется
Russian Federation
Moscow
Competing Interests: Конфликт интересов не заявляется
D. K. Vasiliev
National Medical Center for Preventive Medicine
Russian Federation
Moscow
Competing Interests: Конфликт интересов не заявляется
Russian Federation
Moscow
Competing Interests: Конфликт интересов не заявляется
References
1. de Man FS, Tu L, Handoko ML, et al. Dysregulated reninangiotensin-aldosterone system contributes to pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012;186:7809. doi:10.1164/rccm.201203-0411OC.
2. Juratsch CE, Jengo JA, Castagna J, et al. Experimental pulmonary hypertension produced by surgical and chemical denervation of the pulmonary vasculature. Chest. 1980;77:52530. doi:10.1378/chest.77.4.525.
3. Laks MM, Juratsch CE, Garner D, et al. Acute pulmonary artery hypertension produced by distention of the main pulmonary artery in the conscious dog. Chest. 1975;68:807-13. doi:10.1378/chest.68.6.807.
4. Chen SL, Zhang YJ, Zhou L, et al. Percutaneous pulmonary artery denervation completely abolishes experimental pulmonary arterial hypertension in vivo. EuroIntervention. 2013;22:269-76. doi:10.4244/EIJV9I2A43.
5. Rothman AM, Arnold ND, Chang W, et al. Pulmonary artery denervation reduces pulmonary artery pressure and induces histological changes in an acute porcine model of pulmonary hypertension. Circ Cardiovasc Interv. 2015;8:e002569. doi:10.1161/CIRCINTERVENTIONS.115.002569.
6. Zhou L, Zhang J. Jiang XM, et al. pulmonary artery denervation attenuates pulmonary arterial remodeling in dogs with pulmonary arterial hypertension induced by dehydrogenized monocrotaline. J Am Coll Cardiol Intv. 2015;8:2013-2023. doi:10.1016/j.jcin.2015.09.015.
7. Liu C, Jiang XM, Zhang J, et al. Pulmonary artery denervation improves pulmonary arterial hypertension induced right ventricular dysfunction by modulating the local reninangiotensin aldosterone system. BMC Cardiovasc Disord. 2016;10:192. doi:10.1186/s12872-016-0366-4.
8. Takachi T, Maeda M, Shirakusa T, et al. Sympathetic reinnervation of unilaterally denervated rat lung. Acta Physiol Scand. 1995;154:43-50 doi:10.1111/j.1748-1716.1995.tb09884.x.
9. Leopold JA. Catheter-based therapies for patients with medication-refractory pulmonary arterial hypertension. Circ Cardiovasc Interv. 2015;8:e003332. doi:10.1161/CIRCINTERVENTIONS.115.003332.
10. Chen SL, Zhang FF, Xu J, et al. Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study. J Am Coll Cardiol. 2013;62:1092-1100. doi:10.1016/j.jacc.2013.05.075.
11. Chen SL, Zhang H, Xie DJ, et al. Hemodynamic, functional, and clinical responses to pulmonary artery denervation in patients with pulmonary arterial hypertension of different causes: phase II results from the Pulmonary Artery Denervation-1 study. Circ Cardiovasc Interv. 2015;8:e002837. doi:10.1161/CIRCINTERVENTIONS.115.002837.
12. Hoeper MM, Galiè N. Letter by Hoeper and Galiè regarding article, ‘‘Hemodynamic, functional, and clinical responses to pulmonary artery denervation in patients with pulmonary arterial hypertension of different causes: phase II results from the Pulmonary Artery Denervation-1 study’’. Circ Cardiovasc Interv. 2016;9:e003422. doi:10.1161/CIRCINTERVENTIONS.115.003422.
13. Zhang H, Zhang J, Chen M, et al. Pulmonary artery denervation significantly increases 6-min walk distance for patients with combined preand post-capillary pulmonary hypertension associated with left heart failure: the PADN-5 study. J Am Coll Cardiol Intv. 2019:12:274-84. doi:10.1016/j.jcin.2018.09.021.
14. Zhou L, Zhang J, Jiang XM, et al. Pulmonary artery denervation attenuates pulmonary arterial remodeling in dogs with pulmonary arterial hypertension induced by dehydrogenized monocrotaline. J Am Coll Cardiol Intv. 2015:8:2013-23. doi:10.1016/j.jcin.2015.09.015.
15. Naeije R, Gerges M, Vachiery JL, et al. Hemodynamic phenotyping of pulmonary hypertension in left heart failure. Circ Heart Fail. 2017;10:e004082. doi:10.1161/CIRCHEARTFAILURE.117.004082.
16. Fayyaz AU, Edwards WD, Maleszewski JJ, et al. Global pulmonary vascular remodeling in pulmonary hypertension associated with heart failure and preserved or reduced ejection fraction. Circulation. 2018:13:1796-810. doi:10.1161/CIRCULATIONAHA.117.031608.
17. Fujisawa T, Kataoka M, Kawakami T et al. Pulmonary artery denervation by determining targeted ablation sites for treatment of pulmonary arterial hypertension. Circ Cardiovasc Interv. 2017:10:e005812. doi:10.1161/CIRCINTERVENTIONS.117.005812.
18. Zheleznev SI, Demidov DP, Afanasiev AV, et al. Radiofrequency denervation of pulmonary artery in surgery of dysplastic mitral valve defects with severe pulmonary hypertension. Russian Journal of Cardiology. 2016;(11):70-2. (In Russ.) doi:10.15829/1560-4071-2016-11-70-72.
19. Chernyavskiy AM, Edemskiy AG, Novikova NV, et al. Radiofrequency Pulmonary Artery Ablation for Treatment of Residual Pulmonary Hypertension After Pulmonary Endarterectomy. Kardiologiia. 2018;58(4):15-21. (In Russ.)
20. Rudenko BA, Feshchenko DA, Shanoian AS, et al. Endovascular treatment of the residual thromboembolic pulmonary hypertension after pulmonary thrombendarterectomy with the denervation system symplicity. Cardiovascular Therapy and Prevention. 2018;17(2):43-8. (In Russ.) doi:10.15829/1728-8800-2018-2-43-48.
21. Feshchenko DA, Rudenko BA, Shanoyan AS, et al. Cryoablation method for pulmonary artery sympathetic denervation in patients with pulmonary hypertension secondary to left sided heart disease: interventional technique, safety and results of the hospital phase. Russian Journal of Cardiology. 2019;(8):29-35. (In Russ.) doi:10.15829/1560-4071-2019-8-29-35.
Review
For citations:
Feshchenko D.A., Rudenko B.A., Shanoyan A.S., Drapkina O.M., Kontsevaya A.V., Gavrilova N.E., Shukurov F.B., Vasiliev D.K. Pulmonary artery denervation in patients with pulmonary hypertension: present state and clinical experience. Russian Journal of Cardiology. 2019;(12):162-168. (In Russ.) https://doi.org/10.15829/1560-4071-2019-12-162-168
Views:
1209
Email this article 